BC-CfE Eligibility Criteria for emtricitabine/tenofovir alafenamide (FTC/TAF; Descovy®)

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025